Clinical Trial

Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study

Study acronym: CLEAR
Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Study terminated per sponsor decision due to operational reasons. The termination was not a result of any participant safety concerns.
Summary
The primary objective of this study is to evaluate a blood-based screening test for Colorectal Cancer (CRC).
Protocol Amendment History 4 changes
critical Trial terminated 2026-04-10
notable Enrollment reduced: 1450 -> 14 participants 2026-04-10
notable Primary completion moved earlier: 2027-05 -> 2026-03-27 2026-04-10
minor Completion moved earlier: 2027-05 -> 2026-03-27 2026-04-10
Trial Details
NCT Number NCT07479381
Lead Sponsor Harbinger Health
Conditions Colorectal Cancer (Diagnosis)
Enrollment 14 participants
Start Date 2026-03-20
Primary Completion 2026-03-27 (estimated)
Study Completion 2026-03-27 (estimated)
Updated on ClinicalTrials.gov 2026-04-09